0QLN.LSE Tecan Group AG

Healthcare Commercial Services & Supplies London Exchange
118.22 GBP
Close of Nov 3, 2026
110.99 256.80
Market cap
GBP 1.39B
P/E
24.1x
P/B
-
ROE
4.4%
Dividend yield
0.01%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is 0QLN.LSE undervalued?

Graham number

The Graham number of Tecan Group AG cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Tecan Group AG fundamental analysis

No fundamental analysis for Tecan Group AG yet.

Tecan Group AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Tecan Group AG

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PA…

Full company profile